Beta Glucan 500 Effects on Biological and Immune Age Markers
Beta Glucan
Other Study
Summary
Study start date: August 1, 2025
Actual date on which the first participant was enrolled.This study is focused on understanding how a supplement called Beta Glucan 500 might affect certain biological markers that indicate a person's biological and immune age. It targets healthy adults, aiming to see if this supplement can potentially slow down or alter these age markers. This is important because it could provide insights into maintaining health and longevity by potentially modifying the body's aging process and boosting the immune system. The study involves participants taking two capsules of Beta Glucan 500 daily for 12 weeks. Researchers will use a comprehensive test panel called TruAge to measure changes in markers associated with biological and immune age. This is an open-label study, meaning all participants will know they are receiving the actual supplement, and there is no placebo group. The goal is to observe any changes in these markers over the course of the study to better understand the supplement's effects.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: 1. Adult females or males age ≥ 40 years 2. Ability to read and speak English 3. Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention 4. DunedinPACE estimate of aging \>0.9 Exclusion Criteria: 1. Current diagnosis and treatment for an autoimmune condition 2. Current use of beta-glucan or mushroom dietary supplement 3. Known allergies to beta glucan, yeast, or mushrooms 4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol 6. Participants unable to provide consent
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location